Conference item icon

Conference item

Validation of the survival model including cardiac substructure dosimetry in NSCLC

Abstract:
In lung cancer radiotherapy (RT) high doses are delivered to the heart. We found significant associations between death rate (DR) and high left atrial wall (LAWall) volumes receiving 63-69Gy (LAWallV63-69) and any new or worsening ischaemic or rhythm ECG changes within 6 months of RT in a prospective isotoxic dose-escalation trial of 78 locally advanced non-small cell lung cancer (LA-NSCLC) patients. Here we aim to validate these findings in an independent retrospective cohort.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1016/S0167-8140(18)31057-0

Authors

More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Oncology
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Oncology
Sub department:
CRUK/MRC Ox Inst Radiation Oncology
Role:
Author


Publisher:
Elsevier
Host title:
Radiotherapy and Oncology
Journal:
ESTRO 37 More from this journal
Volume:
127
Pages:
S383-S384
Publication date:
2018-06-18
Acceptance date:
2018-02-09
DOI:
EISSN:
1879-0887
ISSN:
0167-8140


Pubs id:
pubs:900874
UUID:
uuid:ed73b7c5-758d-4a9f-ab2e-dc09af9c68ea
Local pid:
pubs:900874
Source identifiers:
900874
Deposit date:
2018-10-30
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP